Aging in HIV: A Review of Common Comorbidities in People Living With HIV
August 20th 2025This review highlights how people living with HIV are living longer due to antiretroviral therapy but face unique age-related health challenges, including cardiovascular disease, metabolic syndrome, renal dysfunction, neurocognitive decline, immunosenescence, bone loss, and frailty, requiring tailored screening and management strategies.
Biosurveillance: A Critical Tool for Emerging and Reemerging Infectious Diseases
August 19th 2025Biosurveillance is an essential early warning system for detecting and responding to infectious disease threats, helping to prevent localized cases from becoming widespread outbreaks or pandemics. Despite its proven value during crises such as COVID-19, biosurveillance programs often suffer from inconsistent funding and support, underscoring the urgent need for sustained investment and integration into public health infrastructure.
The Escalating Challenges of Gram-Resistant Organisms: The Role of Cefiderocol
August 18th 2025Clinical trial and real-world data, including the PROVE study, support its role as an effective and carbapenem-sparing therapy for serious infections, though outcomes vary depending on pathogen and infection type.
A Holistic Approach to HIV Patient Care
August 18th 2025In the second episode of Allegheny Health Network’s (AHN) Media Day, Cassandra Oehler, MD, provides insights on HIV care at AHN's Positive Health Clinic (PHC), including the comprehensive services they offer and how they are involved in clinical trials using long-acting injectables.
Statistical Weighting Helps Reduce Bias in Observational Studies
August 15th 2025Pranita Tamma, MD, MHS, continues her conversation about a study she was involved in that compared ceftolozane-tazobactam and ceftazidime-avibactam. She discusses the usage of inverse probability weighting with propensity scores to balance patient groups and limit bias.
Finding a Standard Course of Treatment for Bartonella Infections
August 11th 2025Emily Olsen, PhD, offers some insights on this underdiagnosed infection, including describing antimicrobial studies, particularly in biofilm and intracellular environments. Her findings look to create a standardized approach for treating all forms of the different presentations of bartonellosis.